- Changes in attention variables in those who treated with anticholinergic agents for nonmonosymptomatic enuresis
-
Jang G, Im YJ, Suh J, Park K
- KMID: 2471077
- Investig Clin Urol.
- 2020 Mar;61(2):207-215.
- doi: 10.4111/icu.2020.61.2.207
PURPOSE: Brain dysfunction related to areas regarding attention and arousal may occur not only in patients with attention-deficit/hyperactivity disorder (ADHD) but also in patients with enuresis and daytime symptoms. This... -
- CITED
-
- Close
- SHARE
-
- Close
- A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
-
Yu HS, Lee JW, Yu J, Cho MC, Cho SY
- KMID: 2468715
- Int Neurourol J.
- 2019 Dec;23(4):294-301.
- doi: 10.5213/inj.1938076.038
PURPOSE: To investigate the efficacy and safety of 0.4 mg of tamsulosin in patients with nocturia not responding to 0.2 mg. METHODS: Patients with intractable nocturia after treatment with 0.2 mg... -
- CITED
-
- Close
- SHARE
-
- Close
- Neural Correlates of Urinary Retention in Lateral Medullary Infarction
-
Prabhakar , Iqbal Ahmed AS, Vijayakrishnan Nair A, Mathew V, Aaron S, Sivadasan , Alexander
- KMID: 2460732
- Int Neurourol J.
- 2019 Sep;23(3):205-210.
- doi: 10.5213/inj.1836256.128
PURPOSE: The brainstem plays an important role in the control of micturition, and brainstem strokes are known to present with micturition dysfunction. Micturition dysfunction in cases of lateral medullary infarction... -
- CITED
-
- Close
- SHARE
-
- Close
- De novo or resolved urgency and urgency urinary incontinence after midurethral sling operations: How can we properly counsel our patients?
-
Shin JH, Choo MS
- KMID: 2455965
- Investig Clin Urol.
- 2019 Sep;60(5):373-379.
- doi: 10.4111/icu.2019.60.5.373
PURPOSE: To evaluate de novo and resolved urgency and urgency urinary incontinence (UUI) after midurethral sling operations in patients with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI). MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Friction underwear for ease of pulling down in elderly patients with overactive bladder: A prospective randomized control trial
-
You JH, Shin YS, Ko MH, Jeon EJ, You H, Park JK
- KMID: 2444277
- Investig Clin Urol.
- 2019 May;60(3):216-221.
- doi: 10.4111/icu.2019.60.3.216
PURPOSE: Friction underwear was developed by adding small silicon dots in front of the underwear to decrease the time for pulling down underwear in elderly patients with urge incontinence. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Patient utilization survey of mirabegron prescribed for overactive bladder
-
Rahkola-Soisalo P, Balcerzak , Ruotsalainen J, Mikkola TS
- KMID: 2438822
- Investig Clin Urol.
- 2019 Mar;60(2):114-119.
- doi: 10.4111/icu.2019.60.2.114
PURPOSE: Mirabegron, a β3-adrenoreceptor agonist, is used to treat overactive bladder. The factors affecting persistence of mirabegron use or symptom improvement are not thoroughly known, but could be related to... -
- CITED
-
- Close
- SHARE
-
- Close
- Specificity of Lower Urinary Tract Symptoms in Neuromyelitis Optica in Comparison With Multiple Sclerosis Patients
-
Declemy A, Chesnel C, Charlanes , Le Breton , Ismael SS, Amarenco G
- KMID: 2422506
- Int Neurourol J.
- 2018 Sep;22(3):185-191.
- doi: 10.5213/inj.1836050.025
PURPOSE: The aim of this study was to describe lower urinary tract symptoms in neuromyelitis optica (NMO), and to compare these data with urinary disorders observed in multiple sclerosis (MS)... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravesical electrical stimulation treatment for overactive bladder: An observational study
-
Yune JJ, Shen JK, Pierce MA, Hardesty J, Kim J, Siddighi S
- KMID: 2414757
- Investig Clin Urol.
- 2018 Jul;59(4):246-251.
- doi: 10.4111/icu.2018.59.4.246
PURPOSE: Intravesical electrical stimulation treatment (IVES) has been successfully used to treat neurogenic bladder. We report the results of an observational study regarding the use of IVES for women with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
-
Choi H, Bae JH, Oh CY, Jeong SJ, Ko WJ, Choi JB, Seo JT, Lee DH, Kim JC, Lee KW, Kim YH
- KMID: 2409727
- Int Neurourol J.
- 2018 Mar;22(1):51-57.
- doi: 10.5213/inj.1834982.491
PURPOSE: To compare the clinical efficacy of anticholinergics for managing diabetes mellitus-associated overactive bladder (DM OAB) versus idiopathic overactive bladder (OAB) in Korean women. METHODS: We conducted a multicenter, prospective, parallel-group,... -
- CITED
-
- Close
- SHARE
-
- Close
- Is There Any Difference Between Depression and Anxiety in Overactive Bladder According to Sex? A Systematic Review and Meta-Analysis
-
Melotti IG, Juliato CR, Coelho SC, Lima M, Riccetto C
- KMID: 2396156
- Int Neurourol J.
- 2017 Sep;21(3):204-211.
- doi: 10.5213/inj.1734890.445
PURPOSE: Overactive bladder (OAB) is characterized by urinary urgency with or without urge incontinence, accompanied by frequency and nocturia. It affects individuals of all ages and can predispose affected individuals... -
- CITED
-
- Close
- SHARE
-
- Close
- Aggressive diagnosis and treatment for posterior urethral valve as an etiology for vesicoureteral reflux or urge incontinence in children
-
Nakai H, Hyuga T, Kawai S, Kubo T, Nakamura S
- KMID: 2379895
- Investig Clin Urol.
- 2017 Jun;58(Suppl 1):S46-S53.
- doi: 10.4111/icu.2017.58.S1.S46
Vesicoureteral reflux (VUR) is one of the most common diseases in pediatric urology and classified into primary and secondary VUR. Although posterior urethral valve (PUV) is well known as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Sacral Neuromodulation in Patients With a Cardiac Pacemaker
-
Gahzi AA, Elterman D, Hassouna M
- KMID: 2365722
- Int Neurourol J.
- 2016 Sep;20(3):270-272.
- doi: 10.5213/inj.1632536.268
The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With... -
- CITED
-
- Close
- SHARE
-
- Close
- Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms
-
Kosilov KV, Alexandrovich LS, Gennadyevna KI, Viktorovna SO, Sergeevna , Ivanovich
- KMID: 2365718
- Int Neurourol J.
- 2016 Sep;20(3):240-249.
- doi: 10.5213/inj.1632520.260
PURPOSE: The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse
-
Kim MS, Lee GH, Na ED, Jang JH, Kim HC
- KMID: 2351787
- Obstet Gynecol Sci.
- 2016 May;59(3):214-219.
- doi: 10.5468/ogs.2016.59.3.214
OBJECTIVE: The purpose of this study was to evaluate the impact of pelvic organ prolapse (POP) repair on overactive bladder (OAB) symptoms in women with POP and the effect of... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral pharmacological therapy for urinary incontinence
-
Kim DK
- KMID: 2382726
- J Korean Med Assoc.
- 2016 Mar;59(3):215-220.
- doi: 10.5124/jkma.2016.59.3.215
Urinary incontinence (UI) has been a serious health problem which can significantly affect quality of life. UI may occur at any age but more common in the elderly population. Many... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy
-
Hoag N, Tse V, Wang A, Chung E, Gani J
- KMID: 2173132
- Int Neurourol J.
- 2016 Mar;20(1):81-85.
- doi: 10.5213/inj.1630380.190
The efficacy of intravesical onabotulinumtoxinA (BTXA) in the treatment of overactive bladder (OAB) has been well documented. The use of BTXA injection in orthotopic neobladders is yet to be studied.... -
- CITED
-
- Close
- SHARE
-
- Close
- Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent
-
Wang SM, Lee HK, Kweon YS, Lee CT, Lee KU
- KMID: 2171055
- Clin Psychopharmacol Neurosci.
- 2015 Aug;13(2):212-214.
- doi: 10.9758/cpn.2015.13.2.212
Overactive bladder (OAB) is defined as urgency, usually with frequency and nocturia, and with or without urge incontinence. Duloxetine, an antidepressant that inhibits reuptake of serotonin and norepinephrine, is indicated... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result
-
Irkilata L, Aydin M, Aydin HR, Cihan Demirel H, Kadihasanoglu M, Atilla MK
- KMID: 2380832
- Int Neurourol J.
- 2015 Jun;19(2):85-89.
- doi: 10.5213/inj.2015.19.2.85
PURPOSE: This study aimed to verify the efficacy and safety of intravesical treatment with sodium chondroitin sulfate (CS) in patients with overactive bladder (OAB) who are refractory to previous antimuscarinic... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Voiding Dysfunction and Constipation in Children with Attention Deficit Hyperactivity Disorder
-
Kim JY, Lee ES, Bang JS, Oh YJ, Lee YJ, Sung TJ, Lee KH, Lee JW
- KMID: 1733218
- J Korean Soc Pediatr Nephrol.
- 2014 Oct;18(2):71-76.
- doi: 10.3339/jkspn.2014.18.2.71
PURPOSE: Attention deficit hyperactivity disorder (ADHD) has been associated with impairments in frontal inhibitory function and the catecholaminergic system. ADHD is diagnosed in 3-5% of children. Children with ADHD seem... -
- CITED
-
- Close
- SHARE
-
- Close
- The Changes of Voiding Pattern After Midurethral Sling Between Pure Stress Urinary Incontinence and Stress Urinary Incontinence With Overactive Bladder Group
-
Kim SW, Kim WH, Yoon BI, Cho YH, Sohn DW
- KMID: 1885619
- Korean J Urol.
- 2014 Jun;55(6):400-404.
- doi: 10.4111/kju.2014.55.6.400
PURPOSE: The purpose of this study is to compare changes in voiding pattern after midurethral sling surgery (MUS) between the stress urinary incontinence (SUI) group and the overactive bladder (OAB)+SUI... -
- CITED
-
- Close
- SHARE
-
- Close
